Hopkins Biotech Podcast

Hopkins Biotech Podcast
  • ٥٫٠ (١٠)
  • علوم حياة
Hopkins Biotech Podcast

Illuminating life science career opportunities outside of academia through the experiences of those who have been there before.

  1. ٢٣ جمادى الآخرة

    Roivant: Reinventing the Paradigm of Conventional Drug Development

    Roivant Pharma is reinventing the discovery, development, and commercialization of new medicines. Mayukh Sukhatme, M.D. was recently appointed to Roivant's board of directors and has served as Roivant’s President and Chief Investment Officer since January 2021. He is responsible for identifying, performing diligence on, devising development strategies for, and transacting on new therapeutic programs for the company. He also informs Roivant’s view of its existing biopharmaceutical subsidiary c...

    ٥١ من الدقائق

  2. ٠٥‏/٠٦‏/١٤٤٥ هـ

    Public Relations and Scientific Communications for Biotechnology with Ignacio Guerrero-Ros

    Dr. Ignacio Guerrero-Ros is an immunologist turned scientific communicator and biotech media innovator. Currently, he is an Assistant Vice President at Russo Partners, providing public and investor relations services to clients in the healthcare and technology industries. Originally from Spain, Ignacio earned his PhD in Immunology from Albert Einstein College of Medicine. Ignacio embraces the Hopkins Biotech Podcast's mission of the pursuit of alternative careers for PhD holders. In this...

    ٤٤ من الدقائق

  3. ١٧‏/٠٤‏/١٤٤٥ هـ

    What You Should Know About the Biotech Job Market in 2023 with Carina Clingman

    Carina Clingman, Ph.D., is the Founder and CEO of Recruitomics Consulting, a niche talent acquisition and talent strategy firm specializing in biotech startups. She recently founded The Collaboratory Career Hub to help biotech job seekers find confidence and success in their job search. If you're exploring careers in biotech, join the free Collaboratory Slack Community to work directly with Carina and her team. In this episode, we discuss the state of the biotech job market and offer adv...

    ٥٧ من الدقائق

  4. ٢٤‏/٠٣‏/١٤٤٥ هـ

    Antibody-Drug Conjugates: Targeting Cancer Where it is Vulnerable with David Dornan of Elevation Oncology

    About this episode: David Dornan is the Chief Scientific Officer of Elevation Oncology, a clinical-stage biotech company developing targeted cancer therapeutics, with a focus on antibody drug conjugates. David brings to Elevation over two decades of industry and academic oncology drug discovery and development experience. His research spans multiple therapeutic modalities targeting cancer susceptibilities and modulating the immune system to translate into meaningful therapeutic interventions ...

    ٢٩ من الدقائق

  5. ٢٧‏/٠١‏/١٤٤٥ هـ

    Boston Biotech Series: Standing out in the Competitive Recruiting Process for Early Stage Biotech

    Emily Gransky is the Vice President of Recruiting at RA Ventures (RAVen). RAVen is the early-stage venture arm of the multi-stage investment firm RA Capital. In this role, Emily works closely with senior leaders, venture partners, and managing directors within the Venture Team at RA Capital and within RAVen. Her primary responsibility is leading and executing full-cycle recruiting across all newcos and portfolio companies. Prior to RAVen, Emily worked as Director, Talent Acquisition, at Gener...

    ٢٩ من الدقائق

  6. ٢٩‏/١٢‏/١٤٤٤ هـ

    Boston Biotech Series: Building a Drug Development Platform on New Biology with Isaac Klein of Dewpoint Therapeutics

    Dr. Isaac Klein is the Chief Scientific Officer at Dewpoint Therapeutics. Dewpoint Therapeutics is leveraging condensate biology to impact a wide range of therapeutic targets across diverse disease areas. Armed with significant funding from venture capital and several big pharma partnerships, Dewpoint is poised to lead the generation of medicines targeting biomolecular condensates.Prior to joining Dewpoint, Isaac was on the faculty at the Dana Farber Cancer Institute and Harvard Medical Schoo...

    ٣٨ من الدقائق

  7. ٢٦‏/٠٩‏/١٤٤٤ هـ

    Boston Biotech Series: Facilitating Start-up Company Formation with Adam Jenkins of Biolabs

    Dr. Adam Jenkins is the Regional Site Director for the Massachusetts sites of Biolabs. BioLabs is an international, membership-based network of shared lab and office facilities located in key biotech innovation clusters. Since 2009, over 230 companies have launched from Biolabs facilities, and those member companies have collectively raised more than 1 billion dollars in private financing. With a growing number of sites across the globe, Biolabs is enabling company formation and promoting the...

    ٣٦ من الدقائق

  8. ٢٨‏/٠٨‏/١٤٤٤ هـ

    JPM Highlights: What’s Next in ImmunoOncology

    In this episode, we talk with our panel about updates their company gave at the recent JP Morgan Healthcare Conference that took place earlier this year. This once-yearly conference is the epicenter for biotech deal-making and groundbreaking data releases. Dr. Robert Ross is the Chief Executive Officer of Surface Oncology. Surface Oncology’s mission is to deliver transformative outcomes for people with cancer by breaking through the frontiers of immuno-oncology research. Before becoming ...

    ٥٩ من الدقائق
مشاهدة الكل (٨٤)

التقييمات والمراجعات

٥
من ٥
‫١٠ من التقييمات‬

حول

Illuminating life science career opportunities outside of academia through the experiences of those who have been there before.

المعلومات

  • صناع العمل
    Hopkins Biotech Podcast
  • سنوات النشاط
    ١٤٤١ هـ - ١٤٤٥ هـ
  • الحلقات
    ٨٤
  • التقييم
    ملائم
  • حقوق النشر
    © 2024 Hopkins Biotech Podcast
  • موقع البرنامج على الويب
    Hopkins Biotech Podcast

قد يعجبك أيضًا

للاستماع إلى حلقات ذات محتوى فاضح، قم بتسجيل الدخول.

اطلع على آخر مستجدات هذا البرنامج

قم بتسجيل الدخول أو التسجيل لمتابعة البرامج وحفظ الحلقات والحصول على آخر التحديثات.
تحديد بلد أو منطقة

أفريقيا والشرق الأوسط، والهند

آسيا والمحيط الهادئ

أوروبا

أمريكا اللاتينية والكاريبي

الولايات المتحدة وكندا